Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: Eur J Cancer Prev. 2011 Sep;20(5):396–402. doi: 10.1097/CEJ.0b013e3283463943

Figure 5.

Figure 5

Assessment of breast cancer risk in patient population. A, Comparison of breast cancer probability between the patients who did not have CD44 polymorphisms in CD44 exon2 coding region and those who had CD44 polymorphisms in CD44 exon2 coding sequence. Y axis was the probability of NOT having breast cancer. B, Comparison of cumulative risk for breast cancer between the patients having no CD44 polymorphisms and those having CD44 polymorphisms in CD44 exon2 coding region. The Kaplan Meier approach was used to generate both probability and cumulative risk curves. The Gehan rank test was used to determine the statistical difference.